MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinsonism"

  • 2019 International Congress

    CHCHD2 maintains the MICOS and inhibits PINK1/Parkin mediated mitophagy in an experimental model of Parkinson’s disease

    X. Chen, M. Zhou, XQ. Zhu, SX. Huang, WY. Guo, Z. Pei, PY. Xu (Guangzhou, China)

    Objective: To illustrate the mechanism of CHCHD2 in regulating MICOS and mitophagy in Parkinson's disease.To illustrate the mechanism of CHCHD2 in regulating MICOS and mitophagy…
  • 2019 International Congress

    Cervical and Lumbosacral Spondylosis is common in patients with Parkinsonism in rural Western India

    S. Desai (Anand, India)

    Objective: We intended to assess presence of cervical and lumbosacral spondylosis our patients with parkinsonism. Background: We have observed that patients with Parkinson’s disease [PD]…
  • 2019 International Congress

    Nigral Iron Load as Diagnostic Parameter in Parkinson’s Disease

    S. Franthal, L. Pirpamer, N. Homayoon, M. Koegl, P. Katschnig-Winter, K. Wenzel, C. Langkammer, S. Ropele, F. Fazekas, R. Schmidt, P. Schwingenschuh (Graz, Austria)

    Objective: The aim of our study was to determine the diagnostic value of nigral iron depositions in PD, measured by iron specific MRI-techniques. Background: Nigral…
  • 2019 International Congress

    Relationship between intestinal bacteria, bacterial metabolites and residual pesticides in Parkinson’s disease

    M. Hirayama, T. Hamaguchi, M. Ito, T. Ishida, M. Kuki, T. Maeda, K. Kashihara, Y. Tsuboi, K. Ohno (Hukuoka, Japan)

    Objective: We examined the relationship between intestinal bacteria, oral bacteria, bacterial metabolites, residual pesticides and clinical symptoms. Background: Intestinal environment is thought to be involved…
  • 2019 International Congress

    Utilising Magnetic Resonance Spectroscopy to investigate synucleinopathies

    N. Khalil, E. Matar, S. Duffy, S. Lewis (Camperdown, Australia)

    Objective: To study the neuronal integrity of the Anterior (ACC) and Posterior (PCC) Cingulate Cortices with Proton Magnetic Resonance Spectroscopy (H-MRS) across healthy controls (n=17),…
  • 2019 International Congress

    Early postural instability is an effective predictor of future freezing of gait in Parkinson’s disease

    J. Lee (Goyang-Si, Republic of Korea)

    Objective: This prospective cohort study investigated the potential predictor of future FOG occurrence in patients with de novo PD. Background: Freezing of gait (FOG) is…
  • 2019 International Congress

    High intensity interval training elevates circulating BDNF and miRNAs level in patients with idiopathic Parkinson’s disease

    P. Malczynska, B. Kaminski, M. Siemiatycka, A. Pawłowska, I. Przybylska, J. Langfort, J. Marusiak, M. Chalimoniuk (Warsaw, Poland)

    Objective: To investigate if twelve weeks of high intensity interval training (HIIT) can enhance serum  BDNF and miRNAs levels in patients with Parkinson’s disease (PD). Background: BDNF plays several important physiological functions including…
  • 2019 International Congress

    Identification of protein biomarker/s in CSF of Parkinson’s disease (PD) with cognitive impairment

    A. Naskar, A. Stezin, D. Gadara, S. Ahuja, V. Menon, N. Kamble, J. Saini, S. Hegde, U. Tatu, P. Pal, P. Alladi (Bangalore, India)

    Objective: i. To identify CSF protein biomarker/s in Parkinson's disease (PD) with cognitive impairment using LC-MS/MS proteomics. ii. To estimate the level of known AD…
  • 2019 International Congress

    High cost of medications for Parkinson’s Disease patients in a rural population of Gujarat, India

    A. Pandya, E. Albert-Stone, A. Deb, S. Desai (Worcester, MA, USA)

    Objective: To understand the economic burden of the cost of Parkinson’s Disease (PD) medications for outpatients receiving care at Shree Krishna Hospital (SKH)  in Karamsad,…
  • 2019 International Congress

    Cognitive impairment in patients with Parkinson’s syndrome

    SH. Rakhimova, I. Usmonaliev, Y. Musaeva (Tashkent, Uzbekistan)

    Objective: Study the principle of cognitive impairment in Parkinson's syndrome (brain cerebral circulation disorder, backdrop of atherosclerosis). Background: Parkinsonism-neurologic syndrome is a disorderly degenerative disease…
  • « Previous Page
  • 1
  • …
  • 193
  • 194
  • 195
  • 196
  • 197
  • …
  • 388
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • Marc Chagall’s L’homme à La Tète Renversée (Man with His Head Thrown Back) – An Artistic Depiction of Severe Retrocollis in Neurodegeneration with Brain Iron Accumulation
  • An atypical and interesting feature of Parkinson´s disease
  • Patients with Essential Tremor Live Longer than their Relatives
  • Patients with Essential Tremor Live Longer than their Relatives
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley